A szomatosztatin és az emésztorendszer. Klinikai tapasztalatok

Translated title of the contribution: Somatostatin and gastrointestinal tract. Clinical experiences

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The effect of somatostatin on the gastrointestinal tract is complex; it inhibits the release of gastrointestinal hormones, the exocrine function of the stomach, pancreas and bile, decreases motility and influences absorption as well. Based on these diverse effects there was an increased expectation towards the success of somatostatin therapy in various gastrointestinal disorders. The preconditions for somatostatin treatment was created by the development of long acting somatostatin analogues (octreotide, lanreotide). During the last twenty-five years large trials clarified the role of somatostatin analogues in the treatment of various gastrointestinal diseases. This study summarizes shortly these results. Somatostatin analogue treatment could be effective in various pathological conditions of the gastrointestinal tract, however, this therapeutic modality became a part of the clinical routine only in neuroendocrine tumours and adjuvant treatment of oesophageal variceal bleeding and pancreatic fistulas.

Original languageHungarian
Pages (from-to)1535-1540
Number of pages6
JournalOrvosi Hetilap
Volume154
Issue number39
DOIs
Publication statusPublished - Sep 1 2013

Fingerprint

Somatostatin
Gastrointestinal Tract
Pancreatic Fistula
Gastrointestinal Hormones
Octreotide
Neuroendocrine Tumors
Gastrointestinal Diseases
Bile
Pancreas
Stomach
Hemorrhage
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A szomatosztatin és az emésztorendszer. Klinikai tapasztalatok. / Herszényi, L.; Mihály, E.; Tulassay, Z.

In: Orvosi Hetilap, Vol. 154, No. 39, 01.09.2013, p. 1535-1540.

Research output: Contribution to journalArticle

@article{0cc8f9eec81f4fdd93a2513c7d1a05c2,
title = "A szomatosztatin {\'e}s az em{\'e}sztorendszer. Klinikai tapasztalatok",
abstract = "The effect of somatostatin on the gastrointestinal tract is complex; it inhibits the release of gastrointestinal hormones, the exocrine function of the stomach, pancreas and bile, decreases motility and influences absorption as well. Based on these diverse effects there was an increased expectation towards the success of somatostatin therapy in various gastrointestinal disorders. The preconditions for somatostatin treatment was created by the development of long acting somatostatin analogues (octreotide, lanreotide). During the last twenty-five years large trials clarified the role of somatostatin analogues in the treatment of various gastrointestinal diseases. This study summarizes shortly these results. Somatostatin analogue treatment could be effective in various pathological conditions of the gastrointestinal tract, however, this therapeutic modality became a part of the clinical routine only in neuroendocrine tumours and adjuvant treatment of oesophageal variceal bleeding and pancreatic fistulas.",
keywords = "gastrointestinal diseases, octreotid, oesophageal variceal bleeding, somatostatin",
author = "L. Hersz{\'e}nyi and E. Mih{\'a}ly and Z. Tulassay",
year = "2013",
month = "9",
day = "1",
doi = "10.1556/OH.2013.29721",
language = "Hungarian",
volume = "154",
pages = "1535--1540",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "39",

}

TY - JOUR

T1 - A szomatosztatin és az emésztorendszer. Klinikai tapasztalatok

AU - Herszényi, L.

AU - Mihály, E.

AU - Tulassay, Z.

PY - 2013/9/1

Y1 - 2013/9/1

N2 - The effect of somatostatin on the gastrointestinal tract is complex; it inhibits the release of gastrointestinal hormones, the exocrine function of the stomach, pancreas and bile, decreases motility and influences absorption as well. Based on these diverse effects there was an increased expectation towards the success of somatostatin therapy in various gastrointestinal disorders. The preconditions for somatostatin treatment was created by the development of long acting somatostatin analogues (octreotide, lanreotide). During the last twenty-five years large trials clarified the role of somatostatin analogues in the treatment of various gastrointestinal diseases. This study summarizes shortly these results. Somatostatin analogue treatment could be effective in various pathological conditions of the gastrointestinal tract, however, this therapeutic modality became a part of the clinical routine only in neuroendocrine tumours and adjuvant treatment of oesophageal variceal bleeding and pancreatic fistulas.

AB - The effect of somatostatin on the gastrointestinal tract is complex; it inhibits the release of gastrointestinal hormones, the exocrine function of the stomach, pancreas and bile, decreases motility and influences absorption as well. Based on these diverse effects there was an increased expectation towards the success of somatostatin therapy in various gastrointestinal disorders. The preconditions for somatostatin treatment was created by the development of long acting somatostatin analogues (octreotide, lanreotide). During the last twenty-five years large trials clarified the role of somatostatin analogues in the treatment of various gastrointestinal diseases. This study summarizes shortly these results. Somatostatin analogue treatment could be effective in various pathological conditions of the gastrointestinal tract, however, this therapeutic modality became a part of the clinical routine only in neuroendocrine tumours and adjuvant treatment of oesophageal variceal bleeding and pancreatic fistulas.

KW - gastrointestinal diseases

KW - octreotid

KW - oesophageal variceal bleeding

KW - somatostatin

UR - http://www.scopus.com/inward/record.url?scp=84885053282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885053282&partnerID=8YFLogxK

U2 - 10.1556/OH.2013.29721

DO - 10.1556/OH.2013.29721

M3 - Article

C2 - 24058098

AN - SCOPUS:84885053282

VL - 154

SP - 1535

EP - 1540

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 39

ER -